Assessment of the Pharmacoeconomical Effectiveness of Second Stage Personalized Rehabilitation in Children with Primary Immunodeficiencies: the Experience of One Center

Andrei B. Abrosimov(Research Medical Center), Д. С. Блинов(Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology)
Acta medica Eurasica
September 30, 2024
10.47026/2413-4864-2024-3-1-9
Cited by 0

Related Papers

Patient-Derived Non-Muscular Invasive Bladder Cancer Xenografts of Main Molecular Subtypes of the Tumor for Anti-Pd-l1 Treatment Assessment
|Cells|2019|19
Novel Hydroxypyridine Compound Protects Brain Cells against Ischemic Damage In Vitro and In Vivo
|International Journal of Molecular Sciences|2022|16
Novel aminochromone derivative inhibits tumor growth on xenograft model of lung cancer in mice
|Journal of Advanced Pharmaceutical Technology amp Research|2018|14
Prognostic Role of FGFR3 Expression Status and Tumor-Related MicroRNAs Level in Association with PD-L1 Expression in Primary Luminal Non-Muscular Invasive Bladder Carcinoma
|Life|2020|13
Anticancer signal transduction pathways of selenium nanoparticles in mouse colorectal cancer model
|Biochemical and Biophysical Research Communications|2025|12